Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 441 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-03-11 | 2017-08-25 | 444 |
APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 447 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 450 |
APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-02 | 453 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 456 |
APO-PROPAFENONE | 300MG | TABLET | Resolved | 2017-03-11 | 2018-08-30 | 460 |
APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-06-05 | 463 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-03-11 | 2017-05-23 | 466 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 469 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 472 |
APO-REPAGLINIDE | 0.5MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 475 |
APO-REPAGLINIDE | 1.0MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 478 |
APO-REPAGLINIDE | 2.0MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 481 |
APO-RISEDRONATE | 150MG | TABLET | Resolved | 2017-03-11 | 2017-03-15 | 484 |
APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-18 | 487 |
APO-RIZATRIPTAN RPD | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-11 | 2020-07-06 | 490 |
APO-RIZATRIPTAN RPD | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-11 | 2018-09-11 | 493 |
APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2017-03-11 | 2017-08-18 | 504 |
APO-SILDENAFIL R | 20MG | TABLET | Resolved | 2017-03-11 | 2017-08-24 | 507 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |